E1: initial reporter facility name: a batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
|
It was reported that 10 minutes after starting treatment with a revaclear 400, the patient experienced abdominal pain, nausea and vomiting.The patient received 10mg of metoclopramide; however, the symptoms continued.Five minutes later, the patient received 10 mg of dexamethasone.The symptoms were relieved after two minutes.No additional information is available.
|